A new study published in the journal of BMC Pulmonary Medicine showed that 10% of psoriasis patients would have interstitial ...

Psoriasis is a chronic inflammatory disease affecting 2% of the adult population. Common cutaneous manifestations include well-defined red plaques with a silvery-white scale, typically distributed ...

Secukinumab is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Joel Thomas works hard at his job as an I-T specialist. He also works hard to stay healthy despite his history of psoriasis. Joel Thomas I have an echocardiogram done every year just to make sure ...

IT’S not often that one sees avant-garde dresses being displayed at a medical conference, but that was certainly the case during the recent 25th World Congress of Dermatology in Singapore.

are consistent with porcine juvenile pustular psoriaform dermatitis (PJPPD) 1. Figure 2: Photomicrographs of adjacent sections of haired skin over a lesion from the pig in Figure 1, stained with ...

Most people have only one type at a time. Experts believe psoriasis is an autoimmune disease. It means your body thinks its own tissues are foreign invaders to be attacked. With psoriasis ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

Research has found that arachidonic acid can create chemicals that cause inflammation, which may worsen the red, scaly patches seen in psoriasis. Celiac disease is a health condition characterized ...

Skyrizi is important for AbbVie as sales of its Humira (adalimumab) inflammatory disease mega-blockbuster ... a licence for plaque psoriasis, generalised pustular psoriasis, erythrodermic ...

There are two major forms of psoriasis: plaque psoriasis, the more common one, and pustular psoriasis, the more severe but ...

Zasocitinib is under clinical development by Takeda Pharmaceutical and currently in Phase I for Systemic Lupus Erythematosus.